3 and 4 of the eighth edition (1913) of Kraepelin’s textbook (in German) Psychiatrie, which originally appeared in 1896.

Глава 2

Baek, J. H., D. Y. Park, J. Choi, J. S. Kim, J. S. Choi, K. Ha, J. S. Kwon, D. Lee, and K. S. Hong. “Differences between Bipolar I and Bipolar II Disorders in Clinical Features, Comorbidity, and Family History.” Journal of Affective Disorders 131, nos. 1–3 (2011): 59–67. https://doi.org/10.1016/j.jad.2010.11.020.

Cochran, A. L., M. G. McInnis, and D. B. Forger. “Data-Driven Classification of Bipolar I Disorder from Longitudinal Course ofMood.” Translational Psychiatry 6, no. 10 (2016): e912. https://doi.org/10.1038/tp.2016.166. Mondimore_Concise_3pgs.indd 209 3/25/22 5:05 PM 210 References

Coryell, W., N. C. Andreasen, J. Endicott, and M. Keller. “The Significance of Past Mania or Hypomania in the Course and Outcome of Major Depression.” American Journal of Psychiatry 144, no. 3 (1987): 309–15. https://doi.org/10.1176/ajp.144.3.309.

Judd, L. L., H. S. Akiskal, P. J. Schettler, J. Endicott, J. Maser, D. A. Solomon, A. C. Leon, J. A. Rice, and M. B. Keller. “The Long-Term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder.” Archives of General Psychiatry 59, no. 6 (2002): 530–37. https://doi.org/10.1001/archpsyc.59.6.530.

Merikangas, K. R., R. Jin, J.-P. He, R. C. Kessler, S. Lee, N. A. Sampson, M. C. Viana, et al. “Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative.” Archives of General Psychiatry 68, no. 3 (2011): 241–51. https://doi.org/10.1001/archgenpsychiatry.2011.12.

Perugi, G., E. Hantouche, G. Vannucchi, and O. Pinto. “Cyclothymia Reloaded: A Reappraisal of the Most Misconceived Affective Disorder.” Journal of Affective Disorders 183 (2015): 119–33. https://doi.org/10.1016/j.jad.2015.05.004.

Van Meter, A., E. A. Youngstrom, C. Demeter, and R. L. Findling. “Examining the Validity of Cyclothymic Disorder in a Youth Sample: Replication and Extension.” Journal of Abnormal Child Psychology 41, no. 3 (2013): 367–78. https://doi.org/10.1007/s10802-012–9680-1.

Winokur, G., P. J. Clayton, and T. Reich, Manic-Depressive Illness (St. Louis: C. V. Mosby, 1969). Quoted in F. K. Goodwin and K. R. Jamison, Manic-Depressive Illness (New York: Oxford University Press, 1990), 141.

Глава 3

Berk, M., D. L. Copolov, O. D., K. Lu, S. Jeavons, I. Schapkaitz, M. Anderson-Hunt, and A. I. Bush. “N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder – a Double-Blind Randomized Placebo-Controlled Trial.” Biological Psychiatry 64, no. 6 (2008): 468–75. https://doi.org/10.1016/j.biopsych.2008.04.022.

Berk, M., O. Dean, S. M. Cotton, C. S. Gama, F. Kapczinski, B. S. Fernandes, K. Kohlmann, et al. “The Efficacy of N-Acetylcysteine as an Adjunctive Treatment in Bipolar Depression: An Open Label Trial.” Journal of Affective Disorders 135, nos. 1–3 (2011): 389–94. https://doi.org/10.1016/j.jad.2011.06.005. Mondimore_Concise_3pgs.indd 210 3/25/22 5:05 PM References 211

Bowden, C. L., J. R. Calabrese, G. Sachs, L. N. Yatham, S. A. Asghar, M. Hompland, P. Montgomery, N. Earl, T. M. Smoot, and J. DeVeaugh-Geiss (Lamictal 606 Study Group). “A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients with Bipolar I Disorder.” Archives of General Psychiatry 60, no. 4 (2003): 392–400. https://doi.org/10.1001/archpsyc.60.4.392.

Calabrese, J. R., C. L. Bowden, G. Sachs, L. N. Yatham, K. Behnke, O. P. Mehtonen, P. Montgomery, et al. “A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients with Bipolar I Disorder.” Journal of Clinical Psychiatry 64, no. 9 (2003): 1013–24. https://doi.org/10.4088/jcp.v64n0906.

Calabrese, J. R., J. R. Sullivan, C. L. Bowden, T. Suppes, J. F. Goldberg, G. S. Sachs, M. D. Shelton, F. K. Goodwin, M. A. Frye, and V. Kusumakar. “Rash in Multicenter Trials of Lamotrigine in Mood Disorders: Clinical Relevance and Management.” Journal of Clinical Psychiatry 63, no. 11 (2002): 1012–19. https://doi.org/10.4088/jcp.v63n1110.

Centorrino, F., M. J. Albert, J. M. Berry, J. P. Kelleher, V. Fellman, G. Line, A. E. Koukopoulos, J. E. Kidwell, K. V. Fogarty, and R. J. Baldessarini. “Oxcarbazepine: Clinical Experience with Hospitalized Psychiatric Patients.” Bipolar Disorders 5, no. 5 (2003): 370–74. https://doi.org/10.1034/j.1399–5618.2003.00047.x.

Goldberg, J. F., K. E. Burdick, and C. J. Endick. “Preliminary Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Added to Mood Stabilizers for Treatment-Resistant Bipolar Depression.” American Journal of Psychiatry 161, no. 3 (2004): 564–66. https://doi.org/10.1176/appi.ajp.161.3.564.

Lerer, B., N. Moore, E. Meyendorff, S. R. Cho, and S. Gershon. “Carbamazepine versus Lithium in Mania: A Double-Blind Study.” Journal of Clinical Psychiatry 48, no. 3 (1987): 89–93.

Macritchie, K. A., J. R. Geddes, J. Scott, D. R. Haslam, and G. M. Goodwin. “Valproic Acid, Valproate, and Divalproex in the Maintenance Treatment of Bipolar Disorder.” Cochrane Database of Systematic Reviews, no. 3 (2001): art. no. CD003196. https://doi.org/10.1002/14651858.CD003196.

Moore, G. J., B. M. Cortese, D. A. Glitz, C. Zajac-Benitez, J. A. Quiroz, T. W. Uhde, W. C. Drevets, and H. K. Manji. “A Longitudinal Study of the Effects of Lithium Treatment on Prefrontal and Subgenual Mondimore_Concise_3pgs.indd 211 3/25/22 5:05 PM 212 References Prefrontal Gray Matter Volume in Treatment-Responsive Bipolar Disorder Patients.” Journal of Clinical Psychiatry 70, no. 5 (2009): 699–705. https://doi.org/10.4088/JCP.07m03745.

Schou, M. “Forty Years of Lithium Treatment.” Archives of General Psychiatry 54, no. 1 (1997): 9–13. https://doi.org/10.1001/archpsyc.1997.01830130013002.

Shorter, Edward. “The History of Lithium Therapy.” Bipolar Disorders 11, suppl. 2 (2009): 4–9. https://doi.org/10.1111/j.1399–5618.2009.00706.x.

Глава 4

Baptista, T., N. M. Kin, S. Beaulieu, and E. A. de Baptista. “Obesity and Related Metabolic Abnormalities during Antipsychotic Drug Administration: Mechanisms, Management, and Research Perspectives.” Pharmacopsychiatry 35, no. 6 (2002): 205–19. https://doi.org/10.1055/s-2002–36391.

Calabrese, J. R., S. E. Kimmel, M. J. Woyshville, D. J. Rapport, C. J. Faust, P. A. Thompson, and H. Y. Meltzer. “Clozapine for Treatment-Refractory Mania.” American Journal of Psychiatry 153, no. 6 (1996):759–64. https://doi.org/10.1176/ajp.153.6.759.

Hochman, E., A. Krivoy, A. Schaffer, A. Weizman, and A. Valevski. “Antipsychotic Adjunctive Therapy to Mood Stabilizers and 1-Year Rehospitalization Rates in Bipolar Disorder: A Cohort Study.” Bipolar Disorders 18, no. 8 (2016): 684–91. https://doi.org/10.1111/bdi.12459.

Ray, W. A., C. P. Chung, K. T. Murray, K. Hall, and C. M. Stein. “Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death.” New England Journal of Medicine 360, no. 3 (2009): 225–35. https://doi.org/10.1056/NEJMoa0806994.

Sachs, G. S., A. A. Nierenberg, J. R. Calabrese, L. B. Marangell, S. R. Wisniewski, L. Gyulai, E. S. Friedman, et al. “Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression.” New England Journal of Medicine 356, no. 17 (2007): 1711–22. https://doi.org/10.1056/NEJMoa064135.

Глава 5

Bauer, M. S., P. C. Whybrow, and A. Winokur. “Rapid Cycling Bipolar Affective Disorder I: Association with Grade I Hypothyroidism.” Mondimore_Concise_3pgs.indd 212 3/25/22 5:05 PM References 213 Archives of General Psychiatry 47, no. 5 (1990): 427–32. https://doi.org/10.1001/archpsyc.1990.01810170027005.

Berk, M., O. Dean, S. M. Cotton, C. S. Gama, F. Kapczinski, B. S. Fernandes, K. Kohlmann, et al. “The Efficacy of N-Acetylcysteine as an Adjunctive Treatment in Bipolar Depression: An Open Label Trial.” Journal of Affective Disorders 135, nos. 1–3 (2011): 389–94. https://doi.org/10.1016/j.jad.2011.06.005.

Cole, D. P., M. E. Thase, A. G. Mallinger, J. C. Soares, J. F. Luther, D. J. Kupfer, and E. Frank. “Slower Treatment Response in Bipolar Depression Predicted by Lower Pretreatment Thyroid Function.” American Journal of Psychiatry 159, no. 1 (2002): 116–21. https://doi.org/10.1176/appi.ajp.159.1.116.

Dundar, Y., A. Boland, J. Strobl, S. Dodd, A. Haycox, A. Bagust, J. Bogg, R. Dickson, and T. Walley. “Newer Hypnotic Drugs for the Short-Term Management of Insomnia: A Systematic Review and Economic Evaluation.” Health Technology Assessment 8, no. 24 (2004): iii – x. https://doi.org/10.3310/hta8240.

Keck Jr., P. E., J. R. Strawn, and S. L. McElroy. “Pharmacologic Treatment Considerations in Co-occurring Bipolar and Anxiety Disorders.” Journal of Clinical Psychiatry 67, suppl. 1 (2006): 8–15.

Sarris, J., D. Mischoulon, and I. Schweitzer. “Omega-3 for Bipolar Disorder: Meta-analyses of Use in Mania and Bipolar Depression.” Journal of Clinical Psychiatry 73, no. 1 (2012): 81–6. https://doi.org/10.4088/JCP.10r06710.